Cancer News and Research

Latest Cancer News and Research

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

‘Physicians of the mouth’? Dentists absorb the medical billing drill

On a recent Friday morning, more than 30 dentists and dental staffers gathered in a conference room to learn an arcane new skill: how to bill medical insurers.

24 Sep 2018

Scientists discover and characterize human skeletal stem cells

Human skeletal stem cells that become bone, cartilage, or stroma cells have been isolated from fetal and adult bones. This is the first time that skeletal stem cells, which had been observed in rodent models, have been identified in humans.

24 Sep 2018

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long-term.

24 Sep 2018

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Seattle Genetics, Inc. today announced that its collaborator, Takeda Pharmaceutical Company Limited, has received approval from the Japanese Ministry of Health, Labour and Welfare for ADCETRIS (brentuximab vedotin) in combination with doxorubicin, vinblastine and dacarbazine as a frontline treatment option for CD30-positive Hodgkin lymphoma patients in Japan.

24 Sep 2018

SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship

The Society of Nuclear Medicine and Molecular Imaging is pleased to announce the recipients of the 2018-2020 SNMMI Wagner-Torizuka Fellowship.

24 Sep 2018

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

Columbia University has decided to award the Louisa Gross Horwitz Prize 2018.

24 Sep 2018

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

24 Sep 2018

Views of minority women on gender, race/ethnicity may affect how they seek help for health needs

Black women are more likely to be diagnosed at later stages of breast cancer partly due to barriers to timely screening mammography.

24 Sep 2018

NIMHD-funded study to focus on hurricane-related psychosocial stressors

Eight new awards will help researchers examine the health impacts in Puerto Rico and the U.S. Virgin Islands following the physical damage and community-level hardships left by Hurricanes Irma and Maria in 2017.

24 Sep 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

Genomic screening of more than 50,000 people shows that more than 80% of those who carry an identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer don't know it despite frequent interaction with the healthcare system.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

New spinout company to tackle drug-resistant infections with novel antibiotics

Drug-resistant infections are set to kill more people than cancer by 2050. Now a new University of Plymouth spinout company has been established to help tackle the problem - by developing new antibiotics and bringing them to market.

24 Sep 2018

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus-related head and neck cancer.

24 Sep 2018

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

It's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.

24 Sep 2018

New research suggests power of zebrafish as tool for cancer drug discovery

The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes.

24 Sep 2018

Public awareness of urological conditions found to be alarmingly low across Europe

Public awareness of urological conditions is alarmingly low throughout Europe. Results of a new international survey of more than 2,500 responders from 5 countries show that women know more about men's health issues than men do, men have poor knowledge of key urological symptoms and don't take early signs of potentially life-threatening urological conditions seriously.

24 Sep 2018

Vaping among kids and teens a growing concern

The U.S. Food and Drug Administration has expressed concerns about rising incidence of vaping or smoking e-cigarettes among underage students and teenagers.

23 Sep 2018

Study finds excess emissions from diesel cars produced by major auto manufacturers in Europe

In September 2015, the German automaker Volkswagen was found to have illegally cheated federal emissions tests in the United States, by intentionally programming emissions control devices to turn on only during laboratory testing.

21 Sep 2018

Cancer News and Research

Latest Cancer News and Research

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

‘Physicians of the mouth’? Dentists absorb the medical billing drill

Scientists discover and characterize human skeletal stem cells

Researchers analyze response to combination immunotherapy for patients with rare skin cancer

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship

Columbia University announces winners of 2018 Louisa Gross Horwitz Prize

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

Views of minority women on gender, race/ethnicity may affect how they seek help for health needs

NIMHD-funded study to focus on hurricane-related psychosocial stressors

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Study: Over 80% of people who carry identifiable genetic risk for cancer don't know it

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

New spinout company to tackle drug-resistant infections with novel antibiotics

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

Research shows possibility to postpone cumbersome treatment for low-risk MDS patients

New research suggests power of zebrafish as tool for cancer drug discovery

Public awareness of urological conditions found to be alarmingly low across Europe

Vaping among kids and teens a growing concern

Study finds excess emissions from diesel cars produced by major auto manufacturers in Europe

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in